NEW YORK — The US Food and Drug Administration on Monday granted separate Emergency Use Authorizations for a PCR-based SARS-CoV-2 test from Gravity Diagnostics and a sample self-collection kit from RapidRona.
The FDA also said it has reissued EUAs for SARS-CoV-2 tests developed by Roche and Express Gene to reflect their authorized use with additional sample types.